We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.42% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Trex
TREX
$4.39B
| $167M | 0.32% |
1,641,884
+172,076
| +12% | +$18M |
|
77
NVIDIA
NVDA
$4.64T
| $166M | 0.32% |
8,016,110
-1,005,810
| -11% | -$20.9M |
|
78
Domo
DOMO
$175M
| $163M | 0.31% |
1,931,285
+398,349
| +26% | +$34.1M |
|
79
Repligen
RGEN
$7.08B
| $163M | 0.31% |
563,450
-1,028
| -0.2% | -$264K |
|
80
Accenture
ACN
$105B
| $162M | 0.31% |
506,021
+22,323
| +5% | +$7.26M |
|
|
81
GXO Logistics
GXO
$5.98B
| $161M | 0.31% |
+2,051,695
| New | +$161M |
|
82
Blue Owl Capital
OWL
$6.51B
| $160M | 0.3% |
1,282,500
+1,000,000
| +354% | +$13.9M |
|
83
Public Service Enterprise Group
PEG
$39.2B
| $158M | 0.3% |
2,591,827
-22,373
| -0.9% | -$1.4M |
|
84
Advanced Micro Devices
AMD
$704B
| $153M | 0.29% |
1,488,451
-117,522
| -7% | -$12M |
|
85
British American Tobacco
BTI
$136B
| $153M | 0.29% |
4,332,265
+438,480
| +11% | +$16.5M |
|
86
Goldman Sachs
GS
$292B
| $152M | 0.29% |
401,754
-22,262
| -5% | -$8.69M |
|
87
JPMorgan Chase
JPM
$931B
| $152M | 0.29% |
927,052
-50,469
| -5% | -$7.91M |
|
88
Baidu
BIDU
$35.4B
| $150M | 0.29% |
978,463
+105,543
| +12% | +$17.3M |
|
89
Hamilton Lane
HLNE
$3.85B
| $150M | 0.29% |
1,764,500
-32,000
| -2% | -$2.86M |
|
90
BCE
BCE
$20.5B
| $149M | 0.28% |
2,983,537
+35,711
| +1% | +$1.81M |
|
|
INFO
91
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $149M | 0.28% |
1,277,886
+11,424
| +0.9% | +$1.35M |
|
92
StepStone Group
STEP
$3.59B
| $148M | 0.28% |
3,467,483
+64,841
| +2% | +$2.87M |
|
93
PayPal
PYPL
$50.3B
| $147M | 0.28% |
564,422
+108,579
| +24% | +$30.8M |
|
94
Enbridge
ENB
$121B
| $146M | 0.28% |
3,675,423
+40,839
| +1% | +$1.61M |
|
95
Planet Fitness
PLNT
$4.43B
| $146M | 0.28% |
1,860,392
+112,662
| +6% | +$8.56M |
|
96
Arcturus Therapeutics
ARCT
$161M
| $146M | 0.28% |
3,045,288
+17,288
| +0.6% | +$775K |
|
97
Unilever
UL
$142B
| $145M | 0.28% |
2,378,452
+229,626
| +11% | +$14.6M |
|
98
Idexx Laboratories
IDXX
$44.7B
| $139M | 0.26% |
223,426
-55,706
| -20% | -$37.4M |
|
99
Procter & Gamble
PG
$337B
| $139M | 0.26% |
992,944
-13,490
| -1% | -$1.91M |
|
100
Tandem Diabetes Care
TNDM
$1.23B
| $138M | 0.26% |
1,158,738
-115,090
| -9% | -$12.7M |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.